霍图尼亚科尔达塔 (Houttuynia cordata Thunb. 在英语中) 精油抑制扩散性大B细胞淋巴瘤的生长
Youmei Peng1, Shangkun Liu1,2, Xiaoqian Fu1,2
1Henan Key Laboratory for Pharmacology of liver diseases, BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, CHINA.
Journal of oleo science
|March 1, 2026
概括
霍图尼亚科尔达塔 (Houttuynia cordata Thunb. 在英语中) 精油 (HEO) 显示抗瘤作用对扩散型大B细胞淋巴瘤 (DLBCL). HEO通过抑制PI3K/Akt信号通路来抑制DLBCL细胞增殖和瘤生长.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种普遍存在的非霍奇金淋巴瘤亚型,预后不佳,治疗效果有限.
- 霍图尼亚科尔达塔 (Houttuynia cordata Thunb. 在英语中) 是一种亚洲药用植物,具有已知的抗炎和抗瘤特性.
研究的目的:
- 为了研究Houttuynia cordata Thunb.的治疗潜力. 在扩散大B细胞淋巴瘤 (DLBCL) 中的精油 (HEO).
- 阐明HEO在DLBCL中抗瘤活性的潜在分子机制.
主要方法:
- 在DLBCL细胞系 (SUDHL-4) 的体外研究,以评估增殖,细胞亡和细胞周期.
- 在体内研究使用DLBCL无性裸体小鼠异种移植模型来评估瘤生长抑制.
- 网络药理分析和基特异性蛋白质微阵列,以确定受调节的信号通路.
- 西方斑分析以确认蛋白质表达变化和化合物准对接以确定活性成分.
主要成果:
- 在剂量取决的方式中,HEO抑制了DLBCL细胞增殖,诱导了细胞亡和G0/G1细胞周期停止.
- 在体内,HEO显著抑制DLBCL瘤生长,没有观察到毒性.
- 发现HEO可以降低PI3K/Akt信号通路的调节,从而降低p-PI3K和p-Akt水平.
- HEO调节了与亡相关的蛋白质,降低了Bcl-2并增加了Bax和caspase-3的表达.
- 关键的HEO成分,如乙酸,氧化卡里奥菲伦和特宾醇,对PI3K和Akt表现出强烈的结合亲和力.
结论:
- 通过抑制PI3K/Akt信号通路,HEO对DLBCL表现出显著的抗瘤作用.
- 通过向PI3K/Akt路径,HEO证明了作为DLBCL治疗新型治疗剂的潜力.
- 鉴定出HEO的活性成分有助于其在DLBCL中的治疗效果.
相关概念视频
01:18Lymphoid Cells and Tissues
3.5K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.5K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:24B Cell Activation and Differentiation
17.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.4K